A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JNJ-39588146 in Subjects With Heart Failure.
Phase of Trial: Phase II
Latest Information Update: 22 Aug 2014
At a glance
- Drugs JNJ 39588146 (Primary)
- Indications Heart failure
- Focus Adverse reactions; Biomarker; Pharmacodynamics
- 24 Mar 2012 This trial is recruiting in Belgium.
- 24 Mar 2012 Additional location (Italy) added as reported by European Clinical Trials Database.
- 23 Nov 2011 Actual patient number is 62 according to ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History